Inability of single resting arterial blood gas to predict significant hypoxaemia in chronic obstructive pulmonary disease

Internal Medicine Journal

Volumn 42, Issue 4, 2012, Pages 387-394

  Trauer, J M ^a,e   Gielen, C ^a   Trauer, T ^b,c,d   Steinfort, C L ^a  

^a BARWON HEALTH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d ST VINCENT S HOSPITAL   (Australia)

^e Centre for Disease Control   (Australia)

Author keywords

Chronic obstructive pulmonary disease; Oximetry; Oxygen; Oxygen inhalational therapy

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; TIOTROPIUM BROMIDE;

AGE; AGED; ARTERIAL OXYGEN TENSION; ARTICLE; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPOVENTILATION; HYPOXEMIA; MALE; OUTCOME ASSESSMENT; OXIMETRY; OXYGEN SATURATION; PRIORITY JOURNAL; REM SLEEP; SLEEP APNEA SYNDROME;

AGED; AGED, 80 AND OVER; ANOXIA; BLOOD GAS ANALYSIS; BODY MASS INDEX; FEMALE; HUMANS; MALE; OXIMETRY; OXYGEN; POLYSOMNOGRAPHY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SPIROMETRY;

EID: 84859848362     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2010.02405.x     Document Type: Article

References (36)

1. Nocturnal Oxygen Therapy Trial Group. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Ann Intern Med 1980; 93: 391-8.
2. Report of the Medical Research Council Working Party. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Lancet 1981; 1: 681-6.
3. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P etal. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007; 176: 532-55.
4. Tarpy SP, Celli BR. Long-term oxygen therapy. N Engl J Med 1995; 333: 710-14.
5. Weitzenblum E, Sautegeau A, Ehrhart M, Mammosser M, Pelletier A. Long-term oxygen therapy can reverse the progression of pulmonary hypertension in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1985; 131: 493-8.
6. Timms RM, Khaja FU, Williams GW. Hemodynamic response to oxygen therapy in chronic obstructive pulmonary disease. Ann Intern Med 1985; 102: 29-36.
7. Zieliński J, Tobiasz M, Hawrylkiewicz I, Sliwiński P, Palasiewicz G. Effects of long-term oxygen therapy on pulmonary hemodynamics in COPD patients: a 6-year prospective study. Chest 1998; 113: 65-70.
8. Górecka D, Gorzelak K, Sliwiński P, Tobiasz M, Zieliński J. Effect of long-term oxygen therapy on survival in patients with chronic obstructive pulmonary disease with moderate hypoxia. Thorax 1997; 52: 674-9.
9. Chaouat A, Weitzenblum E, Kessler R, Charpentier C, Enrhart M, Schott R etal. A randomized trial of nocturnal oxygen therapy in chronic obstructive pulmonary disease patients. Eur Resp J 1999; 14: 1002-8.
10. 2 above 60mmHg. Am Rev Respir Dis 1992; 145: 1070-6.
11. Croxton TL, Bailey WC. Long-term oxygen treatment in chronic obstructive pulmonary disease: recommendations for future research. Am J Respir Crit Care Med 2006; 174: 373-8.
12. Güell Rous R. Long-term oxygen therapy: are we prescribing appropriately? Int J Chron Obstruct Pulmon Dis 2008; 3: 231-7.
13. Stoller JK, Panos RJ, Krachman S, Doherty DE, Make B; Long-term Oxygen Treatment Trial Research Group. Oxygen therapy for patients with COPD: current evidence and the long-term oxygen treatment trial. Chest 2010; 138: 179-87.
14. Soguel Schenkel N, Burdet L, de Muralt B, Fitting JW. Oxygen saturation during daily activities in chronic obstructive pulmonary disease. Eur Respir J 1996; 9: 2584-9.
15. American Thoracic Society/European Respiratory Society. Standards for the diagnosis and management of patients with COPD. Position paper 2004: 79 [cited 2010 Aug 30]. Available from URL:
16. McDonald CF, Crockett AJ, Young IH. Adult oxygen domiciliary oxygen therapy. Position statement of the Thoracic Society of Australia and New Zealand. Med J Aust 2005; 182: 621-6.
17. Casanova C, Hernández MC, Sánchez A, García Talavera I, de Torres JP, Abreu J etal. Twenty-four-hour ambulatory oxygen monitoring in COPD patients with moderate hypoxemia. Respir Care 2006; 51: 1416-23.
18. Toraldo D, Nicolardi G, De Nuccio F, Lorenzo R, Ambrosino N. Pattern of variables describing desaturator COPD patients, as revealed by cluster analysis. Chest 2005; 128: 3828-37.
19. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A etal. Standardisation of spirometry. Eur Respir J 2005; 26: 319-38.
20. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991; 14: 540-5.
21. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P etal. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007; 176: 532-55.
22. American Academy of Sleep Medicine. The International Classification of Sleep Disorders, Diagnostic and Coding Manual, 2nd edn. Westchester, IL: American Academy of Sleep Medicine; 2005; 165-7.
23. Apprill M, Weitzenblum E. Pulmonary artery hypertension and nocturnal hypoxemia in chronic obstructive bronchopneumopathy. Rev Mal Respir 1991; 8: 13-27.
24. Lewis CA, Fergusson W, Eaton T, Zeng I, Kolbe J. Isolated nocturnal desaturation in COPD: prevalence and impact on quality of life and sleep. Thorax 2009; 64: 133-8.
25. Sliwiński P, Lagosz M, Górecka D, Zieliński J. The adequacy of oxygenation in COPD patients undergoing long-term oxygen therapy assessed by pulse oximetry at home. Eur Respir J 1994; 7: 274-8.
26. Wilson DO, Rogers RM, Wright EC, Anthonisen NR. Body weight in chronic obstructive pulmonary disease. The National Institutes of Health Intermittent Positive Pressure Breathing Trial. Am Rev Respir Dis 1989; 139: 1435-8.
27. Gray-Donald K, Gibbons L, Shapiro SH, Macklem PT, Martin JG. Nutritional status and mortality in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 153: 961-6.
28. Schols AM, Slangen J, Volovics L, Wouters EF. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157: 1791-7.
29. Lewis CA, Eaton TE, Fergusson W, Whyte KF, Garrett JE, Kolbe J. Home overnight pulse oximetry in patients with COPD: more than one recording may be needed. Chest 2003; 123: 1127-33.
30. Zamarrón C, García Paz V, Morete E, del Campo Matías F. Association of chronic obstructive pulmonary disease and sleep apnea consequences. Int J Chron Obstruct Pulmon Dis 2008; 3: 671-82.
31. Douglas NJ. Sleep in patients with chronic obstructive pulmonary disease. Clin Chest Med 1998; 19: 115-25.
32. Weitzenblum E, Chaouat A, Kessler R, Canuet M. Overlap syndrome: obstructive sleep apnea in patients with chronic obstructive pulmonary disease. Proc Am Thorac Soc 2008; 5: 237-41.
33. Catterall JR, Douglas NJ, Calverley PM, Shapiro CM, Brezinova V, Brash HM etal. Transient hypoxemia during sleep in chronic obstructive pulmonary disease is not a sleep apnea syndrome. Am Rev Respir Dis 1983; 128: 24-9.
34. Zamarrón C, Gude F, Otero Y, Alvarez JM, Golpe A, Rodriguez JR. Prevalence of sleep disordered breathing and sleep apnea in 50- to 70-year-old individuals. A survey. Respiration 1999; 66: 317-22.
35. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993; 328: 1230-5.
36. Connors AF Jr, Dawson NV, Thomas C, Harrell FE Jr, Desbiens N, Fulkerson WJ etal. Outcomes following acute exacerbations of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatment). Am J Respir Crit Care Med 1996; 154: 959-67.